{
    "paper_id": "173a835069f4714a52a34e91d6ac344f0dd663bc",
    "metadata": {
        "title": "",
        "authors": [
            {
                "first": "Heng",
                "middle": [],
                "last": "Li",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Shang-Ming",
                "middle": [],
                "last": "Liu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Xiao-Hua",
                "middle": [],
                "last": "Yu",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Shi-Lin",
                "middle": [],
                "last": "Tang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            },
            {
                "first": "Chao-Ke",
                "middle": [],
                "last": "Tang",
                "suffix": "",
                "affiliation": {},
                "email": ""
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "Coronaviruses (CoVs) belong to the subfamily Orthocoronavirinae in the family of Coronaviridae in the order Nidovirales. Within the subfamily Orthocoronavirinae, there are four genera: alpha-coronavirus (\u03b1-CoV), beta-coronavirus (\u03b2-CoV), gamma-coronavirus (\u03b3-CoV) and delta-coronavirus (\u03b4-CoV) [1, 2] . The genome of CoVs is an enveloped, positive single-stranded RNA, and its size varies between 26 kb and 32 kb (the largest genome of known RNA viruses). Both \u03b1-and \u03b2-CoV genera are known to infect mammals, while \u03b4and \u03b3-CoVs infect birds. The recent two outbreaks of viral pneumonia caused by \u03b2-CoVs are severe acute respiratory syndrome coronavirus (SARS) and the Middle East respiratory syndrome coronavirus (MERS). In 2002, the outbreak of SARS-CoV was first reported in China and then spread quickly worldwide, resulting in hundreds of deaths with an 11% mortality rate [3, 4] . In 2012, MERS-CoV was first emerged in Saudi Arabia and subsequently spread in other countries, with a fatality rate of 37% [5] [6] [7] . In both of these epidemics, these viruses are likely originated from bats and then infect humans through another intermediate animal hosts [the civet (Paguma larvata) for SARS-CoV and the camel for MERS-CoV] [8] [9] [10] .",
            "cite_spans": [
                {
                    "start": 294,
                    "end": 297,
                    "text": "[1,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 298,
                    "end": 300,
                    "text": "2]",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 876,
                    "end": 879,
                    "text": "[3,",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 880,
                    "end": 882,
                    "text": "4]",
                    "ref_id": "BIBREF3"
                },
                {
                    "start": 1009,
                    "end": 1012,
                    "text": "[5]",
                    "ref_id": "BIBREF4"
                },
                {
                    "start": 1013,
                    "end": 1016,
                    "text": "[6]",
                    "ref_id": "BIBREF5"
                },
                {
                    "start": 1017,
                    "end": 1020,
                    "text": "[7]",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 1231,
                    "end": 1234,
                    "text": "[8]",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 1235,
                    "end": 1238,
                    "text": "[9]",
                    "ref_id": "BIBREF9"
                },
                {
                    "start": 1239,
                    "end": 1243,
                    "text": "[10]",
                    "ref_id": "BIBREF10"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "Starting from December 2019, a number of patients with pneumonia of unknown etiology emerged in Wuhan city, Hubei Province, China. The genome sequencing has demonstrated that this pneumonia named COVID-19 is caused by a novel coronavirus SARS-CoV2, formally known as 2019-nCoV [11] [12] [13] . Like SARS-CoV and MERS-CoV, this newly emerged SARS-CoV2 belongs to the B lineage of the \u03b2-CoV.",
            "cite_spans": [
                {
                    "start": 277,
                    "end": 281,
                    "text": "[11]",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 282,
                    "end": 286,
                    "text": "[12]",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 287,
                    "end": 291,
                    "text": "[13]",
                    "ref_id": "BIBREF13"
                }
            ],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "To date, COVID-19 has spread rapidly in 72 countries, causing >90,000 confirmed cases and over 2,946 deaths as of 3 March 2020. Considering the global threat, the World Health Organization (WHO) has declared that COVID-19 is a \"Public Health Emergency of International Concern\". However, there are no vaccines against SARS-CoV2 and specific therapeutic drugs for this communicable disease. Thus, a better understanding of SARS-CoV2 is essential for exploring effective vaccines and drugs. In this review, we summarize recent progress of SARS-CoV2 to provide a framework for prevention and treatment of COVID-19.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Introduction"
        },
        {
            "text": "The SARS-CoV2 genome (30 kb in size) encodes a large non-structural polyprotein, open reading frame (ORF) 1a/b, which is further proteolytically cleaved to generate 15/16 proteins, four structural proteins and five accessory proteins (ORF3a, ORF6, ORF7, ORF8 and ORF9) [14] [15] [16] (Figure 1 ). The four structural proteins consist of the spike surface glycoprotein (S), membrane protein (M), envelope protein (E), and nucleocapsid protein (N), which are essential for SARS-CoV2 assembly and infection. The spike surface glycoprotein plays a key role in its attachment to host cells and can be further cleaved by host proteases into an N-terminal S1 subunit and a membrane-bound C-terminal S2 region [17] . The binding of the S1 subunit to a host receptor can destabilize the prefusion trimer, leading to shedding of the S1 subunit and transition of the S2 subunit into a highly stable postfusion conformation [18] .",
            "cite_spans": [
                {
                    "start": 269,
                    "end": 273,
                    "text": "[14]",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 274,
                    "end": 278,
                    "text": "[15]",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 279,
                    "end": 283,
                    "text": "[16]",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 702,
                    "end": 706,
                    "text": "[17]",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 912,
                    "end": 916,
                    "text": "[18]",
                    "ref_id": "BIBREF18"
                }
            ],
            "ref_spans": [
                {
                    "start": 284,
                    "end": 293,
                    "text": "(Figure 1",
                    "ref_id": "FIGREF3"
                }
            ],
            "section": "Structure of SARS-CoV2"
        },
        {
            "text": "In order to engage a host receptor, the receptor-binding domain (RBD) of the S1 subunit undergoes hinge-like conformational movements, which transiently hide or expose the determinants of receptor binding [19, 20] . These two states of the S1 subunit can be regarded as the \"down\" conformation and the \"up\" conformation. The former represents an inaccessible state of the receptor, and the latter corresponds to an accessible state of the receptor [19, 21] . Therefore, understanding the structure and function of the spike protein can help develop monoclonal antibody drugs and guide the design and development of vaccines.",
            "cite_spans": [
                {
                    "start": 205,
                    "end": 209,
                    "text": "[19,",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 210,
                    "end": 213,
                    "text": "20]",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 448,
                    "end": 452,
                    "text": "[19,",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 453,
                    "end": 456,
                    "text": "21]",
                    "ref_id": "BIBREF21"
                }
            ],
            "ref_spans": [],
            "section": "Structure of SARS-CoV2"
        },
        {
            "text": "SARS-CoV2 is the seventh member of the family of CoVs that infect humans. Four human CoVs (HCoV-229E, HCoV-NL63, HCoV-OC43, and HCoV-HKU1) are able to cause a wide range of upper respiratory tract infections (common cold), whereas the SARS-CoV and the MERS-CoV are responsible for atypical pneumonia. The causes of different infection sites are likely related to the presence of dipeptidyl peptidase 4 (DPP4) and angiotensin-converting enzyme 2 (ACE2) in the lower respiratory tract, which are the major human receptors for the surface spike (S) glycoprotein of MERS and SARS-CoV, respectively [22] [23] [24] . The genetic sequence of SARS-CoV2 is at least 70% similar to that SARS-CoV, and SARS-CoV2 is capable of using the same cell entry receptor, ACE2, to infect humans, as SARS-CoV [25, 26] . However, there are more differences in the key S proteins that viruses interact with host cells. SARS-CoV2 spike binds to human ACE2 with approximately 10-to 20-fold higher affinity than the SARS-CoV spike [19] , making it easier to spread from human-to-human.",
            "cite_spans": [
                {
                    "start": 594,
                    "end": 598,
                    "text": "[22]",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 599,
                    "end": 603,
                    "text": "[23]",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 604,
                    "end": 608,
                    "text": "[24]",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 787,
                    "end": 791,
                    "text": "[25,",
                    "ref_id": "BIBREF25"
                },
                {
                    "start": 792,
                    "end": 795,
                    "text": "26]",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 1004,
                    "end": 1008,
                    "text": "[19]",
                    "ref_id": "BIBREF19"
                }
            ],
            "ref_spans": [],
            "section": "Etiology and pathogenesis of COVID-19"
        },
        {
            "text": "Upon entry into alveolar epithelial cells, SARS-CoV2 replicates rapidly and triggers a strong immune response, resulting in cytokine storm syndromes and pulmonary tissue damage.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Etiology and pathogenesis of COVID-19"
        },
        {
            "text": "Cytokine storm syndromes, also known as hypercytokinemia, are a group of disorders characterized by the uncontrolled production of pro-inflammatory cytokines and are important causes of acute respiratory distress syndrome (ARDS) and multiple organ failure [27] [28] [29] .",
            "cite_spans": [
                {
                    "start": 256,
                    "end": 260,
                    "text": "[27]",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 261,
                    "end": 265,
                    "text": "[28]",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 266,
                    "end": 270,
                    "text": "[29]",
                    "ref_id": "BIBREF29"
                }
            ],
            "ref_spans": [],
            "section": "Etiology and pathogenesis of COVID-19"
        },
        {
            "text": "Analysis of the first 99 confirmed cases of SARS-CoV2 infection revealed that cytokine storm syndromes occurred in patients with severe COVID-19 and 17 (17%) had ARDS and, among them, 11 (11%) patients deteriorated within a short period of time and died of multiple organ failure [30] . In addition, the numbers of total T cells, CD4 + T and CD8 + T cells are decreased in patients with SARS-CoV2 infection, and the surviving T cells are functionally exhausted [31] , suggesting a decreased immune function in SARS-CoV2-infected patients.",
            "cite_spans": [
                {
                    "start": 280,
                    "end": 284,
                    "text": "[30]",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 461,
                    "end": 465,
                    "text": "[31]",
                    "ref_id": "BIBREF31"
                }
            ],
            "ref_spans": [],
            "section": "Etiology and pathogenesis of COVID-19"
        },
        {
            "text": "ARDS, decreased immune function, and secondary infection further worsens respiratory failure.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Etiology and pathogenesis of COVID-19"
        },
        {
            "text": "Since December 2019, multiple cases of patients with pneumonia of unknown cause were successively reported from Wuhan ity, Hubei province, China. They shared a history of exposure to the Huanan seafood market in Wuhan city, and it has been confirmed to be an acute respiratory infection caused by a novel CoV. To date, the number of patients without a history of exposure to the Huanan seafood market is significantly increased. Additionally, some cases without a history of travel to Wuhan emerged [32] . These early phenomena suggest the possibility of human-to-human transmission. ",
            "cite_spans": [
                {
                    "start": 499,
                    "end": 503,
                    "text": "[32]",
                    "ref_id": "BIBREF33"
                }
            ],
            "ref_spans": [],
            "section": "Progress and current status of the epidemic"
        },
        {
            "text": "The initial source of SARS-CoV2 is still unknown, although the first cases were linked to the Huanan seafood market in Wuhan city. Besides seafood, it is reported on social media that some wild animals including birds, snakes, marmots, and bats were sold at the Huanan seafood market. It has been reported that environmental samples obtained from the marketplace have come back positive for the novel CoV, but the specific animal has not been identified [33] . More recently, several studies have suggested that bats may be the potential natural host of SARS-CoV2 [26, 34, 35] . The whole genome-wide nucleotide sequences of SARS-CoV2 are 96% identical to a bat coronavirus [26] . Importantly, SARS-CoV2 has been isolated from pangolins and it was found that the isolated pangolin coronavirus genomes have approximately 85.5% to 92.4% similarity to SARS-CoV2 [36] , suggesting that pangolin may ",
            "cite_spans": [
                {
                    "start": 454,
                    "end": 458,
                    "text": "[33]",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 564,
                    "end": 568,
                    "text": "[26,",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 569,
                    "end": 572,
                    "text": "34,",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 573,
                    "end": 576,
                    "text": "35]",
                    "ref_id": "BIBREF36"
                },
                {
                    "start": 674,
                    "end": 678,
                    "text": "[26]",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 859,
                    "end": 863,
                    "text": "[36]",
                    "ref_id": "BIBREF37"
                }
            ],
            "ref_spans": [],
            "section": "Origin of SARS-CoV2"
        },
        {
            "text": "The novel CoV can be transmitted between humans via respiratory droplets. Notably, the respiratory tract is probably not the only route of transmission. Close contact is also a source of transmission of SARS-CoV2. For example, SARS-CoV2 can be transmitted through direct or indirect contact with mucous membranes in the eyes, mouth, or nose [37] [38] [39] . There is also a possibility of aerosol transmission in a relatively closed environment with continuous exposure to high concentrations of aerosol. Moreover, it has been reported that COVID-19 patients have some gastrointestinal symptoms, including diarrhea, nausea, and vomiting [40, 41] . A recent study showed that the enteric symptoms of COVID-19 pneumonia are associated with the invaded ACE2-expressing enterocytes [42] , suggesting that the digestive tract is a potential route of SARS-CoV2 infection besides respiratory tract. However, additional studies are required to test this possibility. In addition, whether transmission of SARS-CoV2 can occur via breast milk or mother-infant vertically has not been determined.",
            "cite_spans": [
                {
                    "start": 341,
                    "end": 345,
                    "text": "[37]",
                    "ref_id": "BIBREF39"
                },
                {
                    "start": 346,
                    "end": 350,
                    "text": "[38]",
                    "ref_id": "BIBREF40"
                },
                {
                    "start": 351,
                    "end": 355,
                    "text": "[39]",
                    "ref_id": "BIBREF41"
                },
                {
                    "start": 637,
                    "end": 641,
                    "text": "[40,",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 642,
                    "end": 645,
                    "text": "41]",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 778,
                    "end": 782,
                    "text": "[42]",
                    "ref_id": "BIBREF44"
                }
            ],
            "ref_spans": [],
            "section": "Transmission route of SARS-CoV2"
        },
        {
            "text": "All populations are generally susceptible to SARS-CoV2. The elderly and people with basic diseases or low immune function are more likely to become severe cases [30, 43] . In addition, pregnant women and newborns infected with SARS-CoV2 are also prone to develop severe pneumonia [44, 45] . Thus, these vulnerable patients should be considered as a focus on the prevention and management of SARS-CoV2 infection.",
            "cite_spans": [
                {
                    "start": 161,
                    "end": 165,
                    "text": "[30,",
                    "ref_id": "BIBREF30"
                },
                {
                    "start": 166,
                    "end": 169,
                    "text": "43]",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 280,
                    "end": 284,
                    "text": "[44,",
                    "ref_id": "BIBREF47"
                },
                {
                    "start": 285,
                    "end": 288,
                    "text": "45]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Susceptible population"
        },
        {
            "text": "The mean incubation period of SARS-CoV2 was estimated to be 3-7 days, ranging from 2 to 14 days [46, 47] , which indicates a long transmission period of SARS-CoV2. It is estimated that SARS-CoV2 latency is consistent with those of other known human CoVs, including non-SARS human CoVs (mean 3 days, range 2-5 days) [48] , SARS-CoV (mean 5 days, range 2-14 days) [49] , and MERS-CoV (mean 5-7 days, range 2-14 days) [50] . Besides, it has been reported that asymptomatic COVID-19 patients during their incubation periods can effectively transmit SARS-CoV2 [51, 52] , which is different from SARS-CoV because most SARS-CoV cases are infected by \"super spreaders\", and SARS-CoV cases can not infect susceptible persons during the incubation period [53] . Taken together, these data fully support the current period of active monitoring recommended by the WHO of 14 days.",
            "cite_spans": [
                {
                    "start": 96,
                    "end": 100,
                    "text": "[46,",
                    "ref_id": "BIBREF49"
                },
                {
                    "start": 101,
                    "end": 104,
                    "text": "47]",
                    "ref_id": "BIBREF50"
                },
                {
                    "start": 315,
                    "end": 319,
                    "text": "[48]",
                    "ref_id": "BIBREF52"
                },
                {
                    "start": 362,
                    "end": 366,
                    "text": "[49]",
                    "ref_id": "BIBREF53"
                },
                {
                    "start": 415,
                    "end": 419,
                    "text": "[50]",
                    "ref_id": "BIBREF54"
                },
                {
                    "start": 555,
                    "end": 559,
                    "text": "[51,",
                    "ref_id": "BIBREF55"
                },
                {
                    "start": 560,
                    "end": 563,
                    "text": "52]",
                    "ref_id": "BIBREF56"
                },
                {
                    "start": 745,
                    "end": 749,
                    "text": "[53]",
                    "ref_id": "BIBREF57"
                }
            ],
            "ref_spans": [],
            "section": "Incubation period"
        },
        {
            "text": "The basic reproduction number is a very important threshold related to the transmissibility of the virus, which is usually expressed as R nought (R 0 ). The R 0 can be implicitly defined as the average number of secondary infections produced by an infectious person. It is generally believed that if R 0 is greater than 1, the number of infected cases will increase exponentially and cause an epidemic or even a pandemic. Liu et al. reviewed the R 0 of the SARS-CoV2 and found that the estimates ranged from 1.4 to 6.49, with a mean of 3.28 [54] , which is higher than those of SARS-CoV (R 0 : 2~5).",
            "cite_spans": [
                {
                    "start": 541,
                    "end": 545,
                    "text": "[54]",
                    "ref_id": "BIBREF58"
                }
            ],
            "ref_spans": [],
            "section": "Basic reproduction number (R 0 ) of SARS-CoV2"
        },
        {
            "text": "At the onset of the disease, the main manifestations of COVID-19 patients were fatigue, fever, dry cough, myalgia and dyspnea, and less common symptoms were nasal congestion, headache, runny nose, sore throat, vomiting, diarrhea. Severe patients often have dyspnea and/or hypoxemia one week after onset, and then septic shock, ARDS, difficult to correct metabolic acidosis, and coagulation dysfunction develop rapidly. Of note, severe and critical patients can also only present with a low fever, or even no obvious fever, and mild patients show only low fever, mild fatigue, and no pneumonia [40, 43] . These asymptomatic cases or mild cases can also spread the SARS-CoV2 between humans.",
            "cite_spans": [
                {
                    "start": 593,
                    "end": 597,
                    "text": "[40,",
                    "ref_id": "BIBREF42"
                },
                {
                    "start": 598,
                    "end": 601,
                    "text": "43]",
                    "ref_id": "BIBREF46"
                }
            ],
            "ref_spans": [],
            "section": "Clinical presentations"
        },
        {
            "text": "Recently, Zhe et al. reported pathological features of the first patient who died from SARS-CoV2 infection [55] . Biopsy samples were obtained from lung tissue of the patient and it was found that the pathological features of COVID-19 are related to ARDS. For example, the evident desquamation of pneumocytes and hyaline membrane formation were seen in the lung tissue, indicating ARDS. Moreover, the inflammatory infiltration of interstitial mononuclear was found in lung tissue. Multinucleated giant cells with atypical enlarged pneumocytes featured by large nucleoli, prominent nucleoli, and amphophilic granular cytoplasm were showed in the intraalveolar spaces, suggesting viral cytopathic-like changes [55] . These pathological characteristics of COVID-19 are highly similar to those seen in SARS-CoV and MERS-CoV infection [56, 57] . Taken together, understanding the pathological characteristics of the severe case of COVID-19 could help provide new insights into the pathogenesis of SARS-CoV-2-infected pneumonia, which may help physicians to formulate a timely strategy for the treatment of similar severe patients and decrease mortality.",
            "cite_spans": [
                {
                    "start": 107,
                    "end": 111,
                    "text": "[55]",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 708,
                    "end": 712,
                    "text": "[55]",
                    "ref_id": "BIBREF59"
                },
                {
                    "start": 830,
                    "end": 834,
                    "text": "[56,",
                    "ref_id": "BIBREF60"
                },
                {
                    "start": 835,
                    "end": 838,
                    "text": "57]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Pathological characteristics"
        },
        {
            "text": "CT is often found to be positive when patients with SARS-CoV2 develop a persistent cough, fever, and unexplained fatigue. Typical CT presentations of COVID-19 patients include bilateral pulmonary parenchymal ground-glass shadow, pulmonary consolidation and nodules, two-sided diffuse distribution, sometimes with a rounded morphology and a peripheral lung distribution [58, 59] . In the early course of diseases, chest images show multiple small patchy shadows and interstitial changes, which is evident in the lung periphery.",
            "cite_spans": [
                {
                    "start": 369,
                    "end": 373,
                    "text": "[58,",
                    "ref_id": "BIBREF63"
                },
                {
                    "start": 374,
                    "end": 377,
                    "text": "59]",
                    "ref_id": "BIBREF64"
                }
            ],
            "ref_spans": [],
            "section": "CT imaging characteristics"
        },
        {
            "text": "Severe cases could spread to the bronchus with the progress of the disease, gradually spread to the whole lung, and with infrequent interlobar pleural thickening and pleural effusion.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "CT imaging characteristics"
        },
        {
            "text": "The rapid and accurate detection of SARS-CoV2 is essential to control the outbreak of COVID. Nucleic acid detection is a major method of laboratory diagnosis. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) is a molecular biological diagnosis technology based on nucleic acid sequences. The complete genomes of SARS-CoV2 sequences are available in Genebank. Thus, the nucleic acid of SARS-CoV2 can be detected by RT-qPCR or by viral gene sequencing of nasopharyngeal and oropharyngeal swabs, stool, sputum, or blood samples [60, 61] . However, the collection of these specimen types by healthcare workers requires close contact with patients, which poses a risk of spreading the virus to the healthcare workers. Moreover, the collection of nasopharyngeal or oropharyngeal specimens may cause bleeding, especially in patients with thrombocytopenia [32] . Importantly, Kelvin et al. found that SARS-CoV2 could be effectively detected in the saliva specimens of infected patients [62] . This suggests that saliva is a promising non-invasive specimen type for diagnosis, monitoring, and infection control of COVID-19 patients.",
            "cite_spans": [
                {
                    "start": 547,
                    "end": 551,
                    "text": "[60,",
                    "ref_id": "BIBREF65"
                },
                {
                    "start": 552,
                    "end": 555,
                    "text": "61]",
                    "ref_id": "BIBREF66"
                },
                {
                    "start": 870,
                    "end": 874,
                    "text": "[32]",
                    "ref_id": "BIBREF33"
                },
                {
                    "start": 1000,
                    "end": 1004,
                    "text": "[62]",
                    "ref_id": "BIBREF67"
                }
            ],
            "ref_spans": [],
            "section": "Detection of SARS-CoV2"
        },
        {
            "text": "Besides RT-qPCR, Zhang et al. described a protocol by using the CRISPR-based SHERLOCK (Specific High Sensitivity Enzymatic Reporter UnLOCKing) technique for the detection of SARS-CoV2 [63] . Using synthetic SARS-CoV2 virus RNA fragments, the authors found that this technique is able to consistently detect target sequences of the SARS-CoV2 in a range between 20 and 200 aM (10-100 copies per microliter of input). This test can be read out using a dipstick in less than 1 hour, without requiring elaborate instrumentation [63] . Compared with RT-qPCR, SHERLOCK technique is more accurate, and the detection time is reduced by half. Thus, the SHERLOCK technique used for the detection of SARS-CoV2 in clinical samples of patients will be expected.",
            "cite_spans": [
                {
                    "start": 184,
                    "end": 188,
                    "text": "[63]",
                    "ref_id": "BIBREF68"
                },
                {
                    "start": 523,
                    "end": 527,
                    "text": "[63]",
                    "ref_id": "BIBREF68"
                }
            ],
            "ref_spans": [],
            "section": "Detection of SARS-CoV2"
        },
        {
            "text": "Suspected and confirmed cases should be treated in designated hospitals with effective isolation and protective conditions. Suspected cases should be treated in a single room and isolated, and confirmed cases can be treated in the same ward. Besides, critical cases need to be admitted to the intensive care unit (ICU) as soon as possible.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Treatments"
        },
        {
            "text": "The general treatment strategies include bed rest and supportive treatments, ensuring sufficient energy intake, maintaining a constant internal environment (water, electrolytes, and other internal environment factors), and monitoring vital signs (heart rate, pulse, blood pressure, oxygen saturation, respiratory rate, etc.). [64, 65] . It has been reported that cynomolgus monkeys are protected from infection with SARS CoV by treatment with IFN-\u03b1 [66] . Moreover, the therapeutic benefit of synthetic recombinant IFN-\u03b1 for patients with SARS was demonstrated in a pilot clinical trial [67] . Thus, IFN-\u03b1 should be considered a candidate drug for COVID therapy.",
            "cite_spans": [
                {
                    "start": 326,
                    "end": 330,
                    "text": "[64,",
                    "ref_id": "BIBREF69"
                },
                {
                    "start": 331,
                    "end": 334,
                    "text": "65]",
                    "ref_id": "BIBREF70"
                },
                {
                    "start": 449,
                    "end": 453,
                    "text": "[66]",
                    "ref_id": "BIBREF71"
                },
                {
                    "start": 587,
                    "end": 591,
                    "text": "[67]",
                    "ref_id": "BIBREF72"
                }
            ],
            "ref_spans": [],
            "section": "General treatments"
        },
        {
            "text": "Lopinavir-ritonavir was first known as a protease inhibitor that can interfere with the replication and synthesis of the human immunodeficiency virus (HIV), leading to the production of immature, non-infectious virus particles [68, 69] . It has been reported that ritonavir and lopinavir can bind to the endopeptidase C30 of SARS-CoV2 protease, which is evaluated by molecular models [70] . This suggests that lopinavir-ritonavir may exert an antiviral effect by inhibiting the protein synthesis of the SARS-CoV2. In addition, several lines of evidence showed that treatment with lopinavir-ritonavir alone or in combination with other antiviral drugs was shown to improve the outcome of severe patients with SARS or MERS by ameliorating ARDS [71] [72] [73] . Given that SARS-CoV2 is similar to these two viruses, lopinavir-ritonavir may have a beneficial effect on COVID-19. Future studies are needed to test this possibility.",
            "cite_spans": [
                {
                    "start": 227,
                    "end": 231,
                    "text": "[68,",
                    "ref_id": "BIBREF73"
                },
                {
                    "start": 232,
                    "end": 235,
                    "text": "69]",
                    "ref_id": "BIBREF74"
                },
                {
                    "start": 384,
                    "end": 388,
                    "text": "[70]",
                    "ref_id": "BIBREF75"
                },
                {
                    "start": 742,
                    "end": 746,
                    "text": "[71]",
                    "ref_id": "BIBREF77"
                },
                {
                    "start": 747,
                    "end": 751,
                    "text": "[72]",
                    "ref_id": "BIBREF78"
                },
                {
                    "start": 752,
                    "end": 756,
                    "text": "[73]",
                    "ref_id": "BIBREF79"
                }
            ],
            "ref_spans": [],
            "section": "Lopinavir/ritonavir (Kaletra)"
        },
        {
            "text": "Ribavirin is a nucleoside analogue with broad antiviral activity. It can prevent the replication of RNA and DNA viruses by suppressing the activity of inosine monophosphate dehydrogenase, which is required for the synthesis of guanosine triphosphate (GTP).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Ribavirin"
        },
        {
            "text": "Ribavirin was widely used to treat SARS patients with or without concomitant use of steroids during the outbreak of SARS in Hong Kong [74] [75] [76] . Thus, ribavirin could be considered as a treatment option for COVID-19 patients.",
            "cite_spans": [
                {
                    "start": 134,
                    "end": 138,
                    "text": "[74]",
                    "ref_id": "BIBREF80"
                },
                {
                    "start": 139,
                    "end": 143,
                    "text": "[75]",
                    "ref_id": "BIBREF81"
                },
                {
                    "start": 144,
                    "end": 148,
                    "text": "[76]",
                    "ref_id": "BIBREF83"
                }
            ],
            "ref_spans": [],
            "section": "Ribavirin"
        },
        {
            "text": "Chloroquine is a widely-used antimalarial and autoimmune disease drug. Recently, chloroquine has been reported as a potential broadspectrum antiviral drug [77, 78] . Wang et al. found that chloroquine effectively suppresses the recently emerged novel CoVs (SARS-CoV2) in vitro [79] . Chloroquine is a cheap and safe drug that has been used for more than 70 years and, thus, it is potentially clinically applicable against COVID-19.",
            "cite_spans": [
                {
                    "start": 155,
                    "end": 159,
                    "text": "[77,",
                    "ref_id": "BIBREF84"
                },
                {
                    "start": 160,
                    "end": 163,
                    "text": "78]",
                    "ref_id": "BIBREF85"
                },
                {
                    "start": 166,
                    "end": 177,
                    "text": "Wang et al.",
                    "ref_id": null
                },
                {
                    "start": 277,
                    "end": 281,
                    "text": "[79]",
                    "ref_id": "BIBREF86"
                }
            ],
            "ref_spans": [],
            "section": "Chloroquine"
        },
        {
            "text": "Arbidol is an antiviral drug against the influenza infection, which is widely used in Russia and China. Arbidol and arbidol mesylate were shown to have a potent inhibitor effect in reducing the reproduction of SARS virus in vitro [80] . Low-level evidence included retrospective cohort, case reports, and case series revealed that arbidol alone or combined with anti-viral drugs produced certain benefits in the treatment of COVID-19 pneumonia [81] [82] [83] . Currently, many randomized clinical control trials are carried out on studying the efficacy of arbidol on COVID-19 pneumonia in China.",
            "cite_spans": [
                {
                    "start": 230,
                    "end": 234,
                    "text": "[80]",
                    "ref_id": null
                },
                {
                    "start": 444,
                    "end": 448,
                    "text": "[81]",
                    "ref_id": "BIBREF89"
                },
                {
                    "start": 449,
                    "end": 453,
                    "text": "[82]",
                    "ref_id": "BIBREF90"
                },
                {
                    "start": 454,
                    "end": 458,
                    "text": "[83]",
                    "ref_id": "BIBREF91"
                }
            ],
            "ref_spans": [],
            "section": "Arbidol"
        },
        {
            "text": "Remdesivir, a nucleoside analogue GS-5734, was reported to inhibit SARS-CoV and MERS-CoV in vivo [84, 85] . More recently, the in vitro study showed that remdesivir potently blocked SARS-CoV2 infection at low-micromolar concentration and showed high selectivity index (SI) [79] . In addition, the first case of SARS-CoV2 infection in the United States was treated with intravenous remdesivir when the patient's condition deteriorated [41] .",
            "cite_spans": [
                {
                    "start": 97,
                    "end": 101,
                    "text": "[84,",
                    "ref_id": "BIBREF92"
                },
                {
                    "start": 102,
                    "end": 105,
                    "text": "85]",
                    "ref_id": "BIBREF93"
                },
                {
                    "start": 273,
                    "end": 277,
                    "text": "[79]",
                    "ref_id": "BIBREF86"
                },
                {
                    "start": 434,
                    "end": 438,
                    "text": "[41]",
                    "ref_id": "BIBREF43"
                }
            ],
            "ref_spans": [],
            "section": "Remdesivir"
        },
        {
            "text": "Although remdesivir has some benefits for the treatment of COVID-19 pneumonia, the randomized controlled trials are still required to determine its efficacy and safety.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Remdesivir"
        },
        {
            "text": "Taken together, these antiviral drugs may be promising treatment options for the treatment of COVID-19. However, there are also a few points worth noting here: 1) The potential interaction of these antiviral drugs with other therapeutic drugs should be considered. 2) It should be noticed that the adverse reactions caused by lopinavir/ritonavir, such as diarrhea, nausea, vomiting and liver damage. 3) It is not recommended to use 3 or more antiviral drugs at the same time, and the use of related drugs should be stopped when there are intolerable side effects. 4) Further evaluation of the efficacy of current antiviral drugs in clinical applications is needed.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Remdesivir"
        },
        {
            "text": "Natural killer (NK) cells are important immune cells necessary for defence against microbe-infected, stressed, or malignant cells. Human NK cells lyse antibody-coated virus-infected cells via the process of antibody-dependent cellular cytotoxicity (ADCC) [86] .",
            "cite_spans": [
                {
                    "start": 255,
                    "end": 259,
                    "text": "[86]",
                    "ref_id": "BIBREF94"
                }
            ],
            "ref_spans": [],
            "section": "NK cell"
        },
        {
            "text": "shown that NK cells can exert antiviral activity by mediating ADCC against SARS, herpes simplex virus type 1 (HSV-1), cytomegalovirus (CMV) and HIV [87] [88] [89] . Umbilical cord blood is a promising source of allogeneic NK cells. Recently, Sorrento and Celularity have announced the launch of a clinical collaboration aimed at extending the use of CYNK-001, an allogeneic, off-the-shelf, umbilical cord blood-derived NK cell therapy, to the treatment of the newly emerged SARS-CoV2 infection [90] . While developing new drugs, new vaccines or clinical trials of old drugs, carrying out NK cell therapy to enhance immunity is currently a very feasible strategy for the treatment and prevention of COVID-19 pneumonia.",
            "cite_spans": [
                {
                    "start": 148,
                    "end": 152,
                    "text": "[87]",
                    "ref_id": "BIBREF95"
                },
                {
                    "start": 153,
                    "end": 157,
                    "text": "[88]",
                    "ref_id": "BIBREF96"
                },
                {
                    "start": 158,
                    "end": 162,
                    "text": "[89]",
                    "ref_id": "BIBREF97"
                },
                {
                    "start": 494,
                    "end": 498,
                    "text": "[90]",
                    "ref_id": "BIBREF98"
                }
            ],
            "ref_spans": [],
            "section": "In this way, NK cells are specific to almost all virus-infected cells. Several studies have"
        },
        {
            "text": "It is well known that mesenchymal stem cells (MSCs) have strong anti-inflammatory and immunomodulatory functions. Umbilical cord blood and placenta are good sources of MSCs.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Mesenchymal stem cell"
        },
        {
            "text": "Numerous studies have shown that treatment with MSCs can ameliorate acute/chronic lung injury and ARDS by suppressing infiltration of immune cells to pulmonary tissues and pro-inflammatory cytokine secretion [91] [92] [93] [94] . In addition, MSCs contribute to reducing lung fibrosis and enhancing tissue repair [95, 96] . Besides routine antiviral treatment, it is important to treat cytokine storm syndromes, ARDS and acute lung injury in patients with severe COVID-19 to prevent the progression of disease and reduce mortality. Thus, MSCs may be a promising therapeutic option for this disease.",
            "cite_spans": [
                {
                    "start": 208,
                    "end": 212,
                    "text": "[91]",
                    "ref_id": "BIBREF99"
                },
                {
                    "start": 213,
                    "end": 217,
                    "text": "[92]",
                    "ref_id": "BIBREF100"
                },
                {
                    "start": 218,
                    "end": 222,
                    "text": "[93]",
                    "ref_id": "BIBREF101"
                },
                {
                    "start": 223,
                    "end": 227,
                    "text": "[94]",
                    "ref_id": "BIBREF102"
                },
                {
                    "start": 313,
                    "end": 317,
                    "text": "[95,",
                    "ref_id": "BIBREF103"
                },
                {
                    "start": 318,
                    "end": 321,
                    "text": "96]",
                    "ref_id": "BIBREF104"
                }
            ],
            "ref_spans": [],
            "section": "Mesenchymal stem cell"
        },
        {
            "text": "Antiviral antibodies (IgG, IgA, IgM, IgE, and IgD) produced in convalescent plasma from recovered patients can effectively treat patients with viral infections. Convalescent plasma therapy has been widely used in infectious diseases, such as poliomyelitis, influenza A (H5N1) and Ebola [97] [98] [99] . In addition, such passive immunization can also be achieved by using convalescent plasma from patients with SARS-CoV infection. It has been reported that a small number of SARS-CoV-infected patients in Taiwan and Hong Kong received the treatment of convalescent plasma during the early course of the disease with certain clinical benefits, including a reduction of plasma viral load from ~10 5 copies/mL to undetectable levels 24 h after plasma transfusion [100] [101] [102] . Thus, convalescent plasma should, theoretically, be a promising option for the treatment and prevention of SARS-CoV2 infection, although this has not been tested clinically.",
            "cite_spans": [
                {
                    "start": 286,
                    "end": 290,
                    "text": "[97]",
                    "ref_id": "BIBREF105"
                },
                {
                    "start": 291,
                    "end": 295,
                    "text": "[98]",
                    "ref_id": "BIBREF106"
                },
                {
                    "start": 296,
                    "end": 300,
                    "text": "[99]",
                    "ref_id": "BIBREF107"
                },
                {
                    "start": 760,
                    "end": 765,
                    "text": "[100]",
                    "ref_id": "BIBREF108"
                },
                {
                    "start": 766,
                    "end": 771,
                    "text": "[101]",
                    "ref_id": "BIBREF109"
                },
                {
                    "start": 772,
                    "end": 777,
                    "text": "[102]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Convalescent plasma therapy"
        },
        {
            "text": "The remission of the SARS-CoV2 epidemic may depend on the development of monoclonal antibodies. Previous studies have identified a number of effective monoclonal antibodies that target SARS-CoV spike protein to prevent the virus from entering host cells [103] [104] [105] . The receptor-binding domain (RBD) of 193 amino acids (residues 318-510) in spike protein is the key target of neutralizing monoclonal antibodies [106] . The SARS-CoV neutralizing monoclonal antibodies CR3014 and CR3022 were found to bind non-competitively to the SARS-CoV RBD and neutralized the virus in a synergistic manner [104] . A recent study showed that CR3022 could combine effectively with SARS-CoV2 RBD (KD of 6.3 nM) [107] . Moreover, the epitope of CR3022 does not overlap with the binding site of ACE2 in SARS-CoV2 RBD [107] . Thus, CR3022 could be a promising therapeutic candidate, alone or in combination with other neutralizing monoclonal antibodies, for the treatment of COVID-19 pneumonia.",
            "cite_spans": [
                {
                    "start": 254,
                    "end": 259,
                    "text": "[103]",
                    "ref_id": "BIBREF112"
                },
                {
                    "start": 260,
                    "end": 265,
                    "text": "[104]",
                    "ref_id": "BIBREF113"
                },
                {
                    "start": 266,
                    "end": 271,
                    "text": "[105]",
                    "ref_id": "BIBREF114"
                },
                {
                    "start": 419,
                    "end": 424,
                    "text": "[106]",
                    "ref_id": "BIBREF115"
                },
                {
                    "start": 600,
                    "end": 605,
                    "text": "[104]",
                    "ref_id": "BIBREF113"
                },
                {
                    "start": 702,
                    "end": 707,
                    "text": "[107]",
                    "ref_id": "BIBREF116"
                },
                {
                    "start": 806,
                    "end": 811,
                    "text": "[107]",
                    "ref_id": "BIBREF116"
                }
            ],
            "ref_spans": [],
            "section": "Monoclonal antibody"
        },
        {
            "text": "Glycyrrhizin, an active component of liquorice roots in Chinese Medicine, could effectively inhibit the replication of SARS-associated coronavirus in vitro [108, 109] . Further, high doses of glycyrrhizin have been used in clinical trials and the drug was reported to be clinically effective for the treatment of SARS at that time [110, 111] . Recently, glycyrrhizin was predicted to have the ability for binding ACE2 with potential anti-COVID-19 effects [112] . Hesperetin, a well-known traditional Chinese medicine, is a natural predominant flavonoid found in citrus fruits. Hesperetin dose-dependently suppresses the cleavage activity of the 3C-like protease (3CLpro) of SARS-CoV in cell-free and cell-based assays [113] . Also, hesperetin was reported to have the potential to inhibit ACE2, therefore, block the infection of SARS-CoV2 [112] . Baicalin, another traditional Chinese herbal medicine, is a flavone isolated from Scutellaria baicalensis. It has been shown that baicalin has antiviral activity against 10 clinical isolates of SARS-CoV by neutralization tests [114] . In addition, quercetin is a plant flavone that is widely used in traditional Chinese medicine and botanical medicine.",
            "cite_spans": [
                {
                    "start": 156,
                    "end": 161,
                    "text": "[108,",
                    "ref_id": "BIBREF117"
                },
                {
                    "start": 162,
                    "end": 166,
                    "text": "109]",
                    "ref_id": "BIBREF118"
                },
                {
                    "start": 331,
                    "end": 336,
                    "text": "[110,",
                    "ref_id": "BIBREF119"
                },
                {
                    "start": 337,
                    "end": 341,
                    "text": "111]",
                    "ref_id": "BIBREF121"
                },
                {
                    "start": 455,
                    "end": 460,
                    "text": "[112]",
                    "ref_id": "BIBREF123"
                },
                {
                    "start": 718,
                    "end": 723,
                    "text": "[113]",
                    "ref_id": "BIBREF124"
                },
                {
                    "start": 839,
                    "end": 844,
                    "text": "[112]",
                    "ref_id": "BIBREF123"
                },
                {
                    "start": 1074,
                    "end": 1079,
                    "text": "[114]",
                    "ref_id": "BIBREF125"
                }
            ],
            "ref_spans": [],
            "section": "Chinese medicine"
        },
        {
            "text": "Quercetin was reported to exert antivirus effects by inhibiting the 3CLpro of SARS-CoV [115] and blocking the entry of SARS-CoV into host cells [116] . Therefore, these studies suggest that Chinese Medicine also plays a key role in the prevention and treatment of COVID-19 pneumonia.",
            "cite_spans": [
                {
                    "start": 87,
                    "end": 92,
                    "text": "[115]",
                    "ref_id": "BIBREF126"
                },
                {
                    "start": 144,
                    "end": 149,
                    "text": "[116]",
                    "ref_id": "BIBREF127"
                }
            ],
            "ref_spans": [],
            "section": "Chinese medicine"
        },
        {
            "text": "SARS-CoV was firstly appeared in 2002 and spread rapidly to 32 countries and regions, and then the world experienced the outbreak of MERS-CoV. Recently, the newly emerged SARS-CoV2 is undoubtedly a warning. It has been confirmed that SARS-CoV2 enter lung cells by binding to ACE2. Besides pulmonary tissue, ACE2 is also highly expressed in other tissues, including bile duct, liver, gastrointestinal organs (small intestine, duodenum), esophagus, testis, and kidney [42, [117] [118] [119] . Thus, these organs may also be damaged by SARS-CoV2. Currently, SARS-CoV2 has spread rapidly in multiple countries, caused severe illness, and sustained human-to-human transmission making it a concerning and serious public health threat. Considering the global threat to health caused by SARS-CoV2, the effective prevention and treatment of COVID-19 pneumonia will be urgently needed.",
            "cite_spans": [
                {
                    "start": 466,
                    "end": 470,
                    "text": "[42,",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 471,
                    "end": 476,
                    "text": "[117]",
                    "ref_id": "BIBREF128"
                },
                {
                    "start": 477,
                    "end": 482,
                    "text": "[118]",
                    "ref_id": "BIBREF130"
                },
                {
                    "start": 483,
                    "end": 488,
                    "text": "[119]",
                    "ref_id": "BIBREF131"
                }
            ],
            "ref_spans": [],
            "section": "Conclusion and future directions"
        },
        {
            "text": "However, the development of drugs for pathogenic SARS-CoV2 is still a major problem for humans, and there are currently no officially approved drugs to treat COVID-19. In view of the epidemiological characteristics of SARS-CoV2, it is crucial to cut off the spread of the virus through the prevention and control methods of epidemic, such as isolating infected patients and controlling the source of infection. At the same time, wild animals trafficking must be banned to reduce the spread of coronavirus. Additionally, it is necessary to make full use of the currently limited evidence for therapeutic drugs to develop strategies of drug application to prevent and control the transmission of SARS-CoV2. It has been confirmed that the genome sequence of SARS-CoV2 shares high identity with that of bat or human SARS-CoV. A number of antiviral drugs and treatment methods for SARS-CoV infection have also been considered for the treatment and prevention of COVID-19 pneumonia.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusion and future directions"
        },
        {
            "text": "We have been warned three times in recent years. CoVs are highly vulnerable to public health intervention strategies, but the increasing incidence of CoV emergence in livestock ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Conclusion and future directions"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "Bats and Coronaviruses",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Banerjee",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kulcsar",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Misra",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Viruses",
            "volume": "11",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "The structure and functions of coronavirus genomic 3' and 5' ends",
            "authors": [
                {
                    "first": "Yang",
                    "middle": [
                        "D"
                    ],
                    "last": "Leibowitz",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "L"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Virus Res",
            "volume": "206",
            "issn": "",
            "pages": "120--133",
            "other_ids": {}
        },
        "BIBREF2": {
            "ref_id": "b2",
            "title": "From SARS to MERS, Thrusting Coronaviruses into the Spotlight",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Bao",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Viruses",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF3": {
            "ref_id": "b3",
            "title": "A decade after SARS: strategies for controlling emerging coronaviruses",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "L"
                    ],
                    "last": "Graham",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "F"
                    ],
                    "last": "Donaldson",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "S"
                    ],
                    "last": "Baric",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Nat Rev Microbiol",
            "volume": "11",
            "issn": "",
            "pages": "836--848",
            "other_ids": {}
        },
        "BIBREF4": {
            "ref_id": "b4",
            "title": "Middle East respiratory syndrome",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zumla",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [
                        "S"
                    ],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Lancet",
            "volume": "386",
            "issn": "",
            "pages": "995--1007",
            "other_ids": {}
        },
        "BIBREF5": {
            "ref_id": "b5",
            "title": "Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "S"
                    ],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "I"
                    ],
                    "last": "Azhar",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "J"
                    ],
                    "last": "Kim",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Lancet Infect Dis",
            "volume": "18",
            "issn": "",
            "pages": "217--227",
            "other_ids": {}
        },
        "BIBREF6": {
            "ref_id": "b6",
            "title": "MERS in South Korea and China: a potential outbreak threat?",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Su",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Lancet",
            "volume": "385",
            "issn": "",
            "pages": "2349--2350",
            "other_ids": {}
        },
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Middle East respiratory syndrome 24",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "B"
                    ],
                    "last": "Reusken",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Haagmans",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Muller",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF8": {
            "ref_id": "b8",
            "title": "coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study",
            "authors": [],
            "year": 2013,
            "venue": "Lancet Infect Dis",
            "volume": "13",
            "issn": "",
            "pages": "859--866",
            "other_ids": {}
        },
        "BIBREF9": {
            "ref_id": "b9",
            "title": "SARS and MERS: recent insights into emerging coronaviruses",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Wit",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Van Doremalen",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Falzarano",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Nat Rev Microbiol",
            "volume": "14",
            "issn": "",
            "pages": "523--534",
            "other_ids": {}
        },
        "BIBREF10": {
            "ref_id": "b10",
            "title": "Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "Wang",
                    "middle": [
                        "Q"
                    ],
                    "last": "Gao",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [
                        "F"
                    ],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Trends Microbiol",
            "volume": "23",
            "issn": "",
            "pages": "468--478",
            "other_ids": {}
        },
        "BIBREF11": {
            "ref_id": "b11",
            "title": "Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Sci China Life Sci",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF12": {
            "ref_id": "b12",
            "title": "COVID-19 in Singapore-Current Experience: Critical Global Issues That Require Attention and Action",
            "authors": [
                {
                    "first": "Jel",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "S"
                    ],
                    "last": "Leo",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "C"
                    ],
                    "last": "Tan",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Jama",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF13": {
            "ref_id": "b13",
            "title": "Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia",
            "authors": [
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF14": {
            "ref_id": "b14",
            "title": "Insights into Cross-species Evolution of Novel Human Coronavirus 2019-nCoV and Defining Immune Determinants for Vaccine Development",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Ramaiah",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [],
                    "last": "Arumugaswami",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.01.29.925867v2.2020"
                ]
            }
        },
        "BIBREF15": {
            "ref_id": "b15",
            "title": "Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "H"
                    ],
                    "last": "Kok",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Emerg Microbes Infect",
            "volume": "9",
            "issn": "",
            "pages": "221--236",
            "other_ids": {}
        },
        "BIBREF16": {
            "ref_id": "b16",
            "title": "Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Peng",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Cell Host Microbe",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF17": {
            "ref_id": "b17",
            "title": "Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Nat Commun",
            "volume": "8",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF18": {
            "ref_id": "b18",
            "title": "Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion",
            "authors": [
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Walls",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Xiong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "J"
                    ],
                    "last": "Park",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "Cell",
            "volume": "176",
            "issn": "",
            "pages": "1026--1039",
            "other_ids": {}
        },
        "BIBREF19": {
            "ref_id": "b19",
            "title": "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wrapp",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "S"
                    ],
                    "last": "Corbett",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Science",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF20": {
            "ref_id": "b20",
            "title": "Structure, Function, and Evolution of Coronavirus Spike Proteins",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Annu Rev Virol",
            "volume": "3",
            "issn": "",
            "pages": "237--261",
            "other_ids": {}
        },
        "BIBREF21": {
            "ref_id": "b21",
            "title": "Cryo-electron microscopy structures of the SARS-CoV spike glycoprotein reveal a prerequisite conformational state for receptor binding",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Gui",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Song",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Cell Res",
            "volume": "27",
            "issn": "",
            "pages": "119--129",
            "other_ids": {}
        },
        "BIBREF22": {
            "ref_id": "b22",
            "title": "Coronavirus Infections-More Than Just the Common Cold",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "I"
                    ],
                    "last": "Paules",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [
                        "D"
                    ],
                    "last": "Marston",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Fauci",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Jama",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF23": {
            "ref_id": "b23",
            "title": "Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "S"
                    ],
                    "last": "Raj",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Mou",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "L"
                    ],
                    "last": "Smits",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Nature",
            "volume": "495",
            "issn": "",
            "pages": "251--254",
            "other_ids": {}
        },
        "BIBREF24": {
            "ref_id": "b24",
            "title": "A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury",
            "authors": [
                {
                    "first": "K",
                    "middle": [],
                    "last": "Kuba",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Imai",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Rao",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nat Med",
            "volume": "11",
            "issn": "",
            "pages": "875--879",
            "other_ids": {}
        },
        "BIBREF25": {
            "ref_id": "b25",
            "title": "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health -The latest 2019 novel coronavirus outbreak in Wuhan, China",
            "authors": [
                {
                    "first": "D",
                    "middle": [
                        "S"
                    ],
                    "last": "Hui",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Ia",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [
                        "A"
                    ],
                    "last": "Madani",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Int J Infect Dis",
            "volume": "91",
            "issn": "",
            "pages": "264--266",
            "other_ids": {}
        },
        "BIBREF26": {
            "ref_id": "b26",
            "title": "A pneumonia outbreak associated with a new coronavirus of probable bat origin",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "L"
                    ],
                    "last": "Yang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "G"
                    ],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nature",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF27": {
            "ref_id": "b27",
            "title": "Lung Repair and Regeneration in ARDS: Role of PECAM1 and Wnt Signaling",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Villar",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "S"
                    ],
                    "last": "Slutsky",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "Chest",
            "volume": "155",
            "issn": "",
            "pages": "587--594",
            "other_ids": {}
        },
        "BIBREF28": {
            "ref_id": "b28",
            "title": "Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Channappanavar",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Perlman",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Semin Immunopathol",
            "volume": "39",
            "issn": "",
            "pages": "529--539",
            "other_ids": {}
        },
        "BIBREF29": {
            "ref_id": "b29",
            "title": "The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Ma",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Am J Emerg Med",
            "volume": "26",
            "issn": "",
            "pages": "711--715",
            "other_ids": {}
        },
        "BIBREF30": {
            "ref_id": "b30",
            "title": "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Dong",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "507--513",
            "other_ids": {}
        },
        "BIBREF31": {
            "ref_id": "b31",
            "title": "Reduction and Functional Exhaustion of T Cells in Patients with Coronavirus Disease",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Diao",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Tan",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF33": {
            "ref_id": "b33",
            "title": "A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "H"
                    ],
                    "last": "Kok",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "514--523",
            "other_ids": {}
        },
        "BIBREF34": {
            "ref_id": "b34",
            "title": "Return of the Coronavirus: 2019-nCoV",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "E"
                    ],
                    "last": "Gralinski",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "D"
                    ],
                    "last": "Menachery",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Viruses",
            "volume": "12",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF35": {
            "ref_id": "b35",
            "title": "Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding",
            "authors": [
                {
                    "first": "R",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Zhao",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF36": {
            "ref_id": "b36",
            "title": "A Novel Coronavirus from Patients with Pneumonia in China",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2019,
            "venue": "N Engl J Med",
            "volume": "382",
            "issn": "",
            "pages": "727--733",
            "other_ids": {}
        },
        "BIBREF37": {
            "ref_id": "b37",
            "title": "Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China",
            "authors": [
                {
                    "first": "Tt-Y",
                    "middle": [],
                    "last": "Lam",
                    "suffix": ""
                },
                {
                    "first": "Mh-H",
                    "middle": [],
                    "last": "Shum",
                    "suffix": ""
                },
                {
                    "first": "H-C",
                    "middle": [],
                    "last": "Zhu",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF39": {
            "ref_id": "b39",
            "title": "2019-nCoV transmission through the ocular surface must not be ignored",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "W"
                    ],
                    "last": "Lu",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [
                        "F"
                    ],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [
                        "F"
                    ],
                    "last": "Jia",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF40": {
            "ref_id": "b40",
            "title": "Novel Wuhan (2019-nCoV) Coronavirus",
            "authors": [
                {
                    "first": "W",
                    "middle": [
                        "G"
                    ],
                    "last": "Carlos",
                    "suffix": ""
                },
                {
                    "first": "Dela",
                    "middle": [],
                    "last": "Cruz",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "S"
                    ],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Am J Respir Crit Care Med",
            "volume": "201",
            "issn": "",
            "pages": "7--8",
            "other_ids": {}
        },
        "BIBREF41": {
            "ref_id": "b41",
            "title": "Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xia",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Tong",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Med Virol",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF42": {
            "ref_id": "b42",
            "title": "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF43": {
            "ref_id": "b43",
            "title": "First Case of 2019 Novel Coronavirus in the United States",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Holshue",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Debolt",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lindquist",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF44": {
            "ref_id": "b44",
            "title": "The digestive system is a potential route of 2019-nCov infection: a bioinformatics analysis based on single-cell transcriptomes",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Kang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Gong",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF46": {
            "ref_id": "b46",
            "title": "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "497--506",
            "other_ids": {}
        },
        "BIBREF47": {
            "ref_id": "b47",
            "title": "Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF49": {
            "ref_id": "b49",
            "title": "Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Backer",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Klinkenberg",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Wallinga",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Euro Surveill",
            "volume": "25",
            "issn": "",
            "pages": "20--28",
            "other_ids": {}
        },
        "BIBREF50": {
            "ref_id": "b50",
            "title": "The incubation period of 2019-nCoV from publicly reported confirmed cases: estimation and application",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "A"
                    ],
                    "last": "Lauer",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "H"
                    ],
                    "last": "Grantz",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Bi",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF52": {
            "ref_id": "b52",
            "title": "Incubation periods of acute respiratory viral infections: a systematic review",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Lessler",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [
                        "G"
                    ],
                    "last": "Reich",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Brookmeyer",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Lancet Infect Dis",
            "volume": "9",
            "issn": "",
            "pages": "291--300",
            "other_ids": {}
        },
        "BIBREF53": {
            "ref_id": "b53",
            "title": "Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Varia",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Wilson",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Sarwal",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Canada. Cmaj",
            "volume": "169",
            "issn": "",
            "pages": "285--292",
            "other_ids": {}
        },
        "BIBREF54": {
            "ref_id": "b54",
            "title": "Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Assiri",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "A"
                    ],
                    "last": "Al-Tawfiq",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Al-Rabeeah",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Lancet Infect Dis",
            "volume": "13",
            "issn": "",
            "pages": "752--761",
            "other_ids": {}
        },
        "BIBREF55": {
            "ref_id": "b55",
            "title": "Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Rothe",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Schunk",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Sothmann",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "N Engl J Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF56": {
            "ref_id": "b56",
            "title": "Effectiveness of airport screening at detecting travellers infected with novel coronavirus (2019-nCoV)",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "J"
                    ],
                    "last": "Quilty",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Clifford",
                    "suffix": ""
                },
                {
                    "first": "Cmmid",
                    "middle": [],
                    "last": "Vwg",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Euro Surveill",
            "volume": "25",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF57": {
            "ref_id": "b57",
            "title": "Transmission dynamics and control of severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Lipsitch",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Cohen",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Cooper",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Science",
            "volume": "300",
            "issn": "",
            "pages": "1966--1970",
            "other_ids": {}
        },
        "BIBREF58": {
            "ref_id": "b58",
            "title": "The reproductive number of COVID-19 is higher compared to SARS coronavirus",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Liu",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "A"
                    ],
                    "last": "Gayle",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Wilder-Smith",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "J Travel Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF59": {
            "ref_id": "b59",
            "title": "Pathological findings of COVID-19 associated with acute respiratory distress syndrome",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Lancet Respir Med",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF60": {
            "ref_id": "b60",
            "title": "The clinical pathology of severe acute respiratory syndrome (SARS): a report from China",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ding",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "J Pathol",
            "volume": "200",
            "issn": "",
            "pages": "282--289",
            "other_ids": {}
        },
        "BIBREF62": {
            "ref_id": "b62",
            "title": "Ultrastructural Findings of a Fatal Case of Middle East Respiratory Syndrome Coronavirus Infection in the United Arab Emirates",
            "authors": [],
            "year": 2014,
            "venue": "Am J Pathol",
            "volume": "186",
            "issn": "",
            "pages": "652--658",
            "other_ids": {}
        },
        "BIBREF63": {
            "ref_id": "b63",
            "title": "CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV)",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Chung",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Bernheim",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Mei",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF64": {
            "ref_id": "b64",
            "title": "Evolution of CT Manifestations in a Patient Recovered from 2019 Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Shi",
                    "suffix": ""
                },
                {
                    "first": "Han",
                    "middle": [
                        "X"
                    ],
                    "last": "Zheng",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Radiology",
            "volume": "2020",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF65": {
            "ref_id": "b65",
            "title": "Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR",
            "authors": [
                {
                    "first": "V",
                    "middle": [
                        "M"
                    ],
                    "last": "Corman",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Landt",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kaiser",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Euro Surveill",
            "volume": "25",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF66": {
            "ref_id": "b66",
            "title": "Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia",
            "authors": [
                {
                    "first": "Dkw",
                    "middle": [],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Pan",
                    "suffix": ""
                },
                {
                    "first": "Sms",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Chem",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF67": {
            "ref_id": "b67",
            "title": "Consistent detection of 2019 novel coronavirus in saliva",
            "authors": [
                {
                    "first": "K",
                    "middle": [
                        "K"
                    ],
                    "last": "To",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [
                        "T"
                    ],
                    "last": "Tsang",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Chik-Yan Yip",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Clin Infect Dis",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF68": {
            "ref_id": "b68",
            "title": "A protocol for detection of COVID-19 using CRISPR diagnostics",
            "authors": [
                {
                    "first": "Feng",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "Omar",
                    "middle": [
                        "O"
                    ],
                    "last": "Abudayyeh",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Gootenberg",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Js",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF69": {
            "ref_id": "b69",
            "title": "Severe acute respiratory syndrome-related coronavirus is inhibited by interferon-alpha",
            "authors": [
                {
                    "first": "U",
                    "middle": [],
                    "last": "Stroher",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Dicaro",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Infect Dis",
            "volume": "189",
            "issn": "",
            "pages": "1164--1167",
            "other_ids": {}
        },
        "BIBREF70": {
            "ref_id": "b70",
            "title": "Characterization of the antiviral effects of interferon-alpha against a SARS-like coronoavirus infection in vitro",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zorzitto",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "L"
                    ],
                    "last": "Galligan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "J"
                    ],
                    "last": "Ueng",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Cell Res",
            "volume": "16",
            "issn": "",
            "pages": "220--229",
            "other_ids": {}
        },
        "BIBREF71": {
            "ref_id": "b71",
            "title": "Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "L"
                    ],
                    "last": "Haagmans",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Kuiken",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [
                        "E"
                    ],
                    "last": "Martina",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Nat Med",
            "volume": "10",
            "issn": "",
            "pages": "290--293",
            "other_ids": {}
        },
        "BIBREF72": {
            "ref_id": "b72",
            "title": "Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "R"
                    ],
                    "last": "Loutfy",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "M"
                    ],
                    "last": "Blatt",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "A"
                    ],
                    "last": "Siminovitch",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Jama",
            "volume": "290",
            "issn": "",
            "pages": "3222--3228",
            "other_ids": {}
        },
        "BIBREF73": {
            "ref_id": "b73",
            "title": "Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Walmsley",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Bernstein",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "King",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "N Engl J Med",
            "volume": "346",
            "issn": "",
            "pages": "2039--2046",
            "other_ids": {}
        },
        "BIBREF74": {
            "ref_id": "b74",
            "title": "Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Pulido",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "R"
                    ],
                    "last": "Arribas",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Delgado",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Aids",
            "volume": "22",
            "issn": "",
            "pages": "1--9",
            "other_ids": {}
        },
        "BIBREF75": {
            "ref_id": "b75",
            "title": "Molecular Modeling Evaluation of the Binding Abilities of Ritonavir and Lopinavir to Wuhan Pneumonia Coronavirus Proteases",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Shen",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF77": {
            "ref_id": "b77",
            "title": "Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "M"
                    ],
                    "last": "Chu",
                    "suffix": ""
                },
                {
                    "first": "V",
                    "middle": [
                        "C"
                    ],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [
                        "F"
                    ],
                    "last": "Hung",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Thorax",
            "volume": "59",
            "issn": "",
            "pages": "252--256",
            "other_ids": {}
        },
        "BIBREF78": {
            "ref_id": "b78",
            "title": "Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV",
            "authors": [
                {
                    "first": "T",
                    "middle": [
                        "P"
                    ],
                    "last": "Sheahan",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Sims",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "R"
                    ],
                    "last": "Leist",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Nat Commun",
            "volume": "11",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF79": {
            "ref_id": "b79",
            "title": "Coronaviruses -drug discovery and therapeutic options",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Zumla",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "F"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "I"
                    ],
                    "last": "Azhar",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Nat Rev Drug Discov",
            "volume": "15",
            "issn": "",
            "pages": "327--347",
            "other_ids": {}
        },
        "BIBREF80": {
            "ref_id": "b80",
            "title": "Managing SARS amidst uncertainty",
            "authors": [
                {
                    "first": "R",
                    "middle": [
                        "P"
                    ],
                    "last": "Wenzel",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "B"
                    ],
                    "last": "Edmond",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "N Engl J Med",
            "volume": "348",
            "issn": "",
            "pages": "1947--1948",
            "other_ids": {}
        },
        "BIBREF81": {
            "ref_id": "b81",
            "title": "Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids",
            "authors": [
                {
                    "first": "B",
                    "middle": [
                        "M"
                    ],
                    "last": "Jones",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "S"
                    ],
                    "last": "Ma",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Peiris",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF83": {
            "ref_id": "b83",
            "title": "Coronavirus as a possible cause of severe acute respiratory syndrome",
            "authors": [
                {
                    "first": "J",
                    "middle": [
                        "S"
                    ],
                    "last": "Peiris",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [
                        "T"
                    ],
                    "last": "Lai",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "L"
                    ],
                    "last": "Poon",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Lancet",
            "volume": "361",
            "issn": "",
            "pages": "1319--1325",
            "other_ids": {}
        },
        "BIBREF84": {
            "ref_id": "b84",
            "title": "New insights into the antiviral effects of chloroquine",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Savarino",
                    "suffix": ""
                },
                {
                    "first": "Di",
                    "middle": [],
                    "last": "Trani",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Donatelli",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Lancet Infect Dis",
            "volume": "6",
            "issn": "",
            "pages": "67--69",
            "other_ids": {}
        },
        "BIBREF85": {
            "ref_id": "b85",
            "title": "Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yan",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Zou",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Sun",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Cell Res",
            "volume": "23",
            "issn": "",
            "pages": "300--302",
            "other_ids": {}
        },
        "BIBREF86": {
            "ref_id": "b86",
            "title": "Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Cao",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Cell Res",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF89": {
            "ref_id": "b89",
            "title": "Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Lu",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Biosci Trends",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF90": {
            "ref_id": "b90",
            "title": "Therapeutic and triage strategies for 2019 novel coronavirus disease in fever clinics. The Lancet Respiratory Medicine",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Yang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF91": {
            "ref_id": "b91",
            "title": "Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series",
            "authors": [
                {
                    "first": "X-W",
                    "middle": [],
                    "last": "Xu",
                    "suffix": ""
                },
                {
                    "first": "X-X",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "X-G",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "bmj",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF92": {
            "ref_id": "b92",
            "title": "Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Wit",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Feldmann",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cronin",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Proc Natl Acad Sci",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF93": {
            "ref_id": "b93",
            "title": "Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "L"
                    ],
                    "last": "Agostini",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "L"
                    ],
                    "last": "Andres",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "C"
                    ],
                    "last": "Sims",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "mBio",
            "volume": "9",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF94": {
            "ref_id": "b94",
            "title": "Natural killer cell specificity for viral infections",
            "authors": [
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Hammer",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Ruckert",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Romagnani",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Nat Immunol",
            "volume": "19",
            "issn": "",
            "pages": "800--808",
            "other_ids": {}
        },
        "BIBREF95": {
            "ref_id": "b95",
            "title": "Molecular Basis for the Recognition of Herpes Simplex Virus Type 1 Infection by Human Natural Killer Cells",
            "authors": [
                {
                    "first": "H",
                    "middle": [
                        "S"
                    ],
                    "last": "Dai",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Caligiuri",
                    "suffix": ""
                }
            ],
            "year": 2018,
            "venue": "Front Immunol",
            "volume": "9",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF96": {
            "ref_id": "b96",
            "title": "Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Arase",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "S"
                    ],
                    "last": "Mocarski",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "E"
                    ],
                    "last": "Campbell",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Science",
            "volume": "296",
            "issn": "",
            "pages": "1323--1326",
            "other_ids": {}
        },
        "BIBREF97": {
            "ref_id": "b97",
            "title": "The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome",
            "authors": [],
            "year": 2004,
            "venue": "Am J Clin Pathol",
            "volume": "121",
            "issn": "",
            "pages": "507--511",
            "other_ids": {}
        },
        "BIBREF98": {
            "ref_id": "b98",
            "title": "Sorrento and Celularity to Initiate Emergency Allogeneic Natural Killer (NK) Cell Therapy Development for Coronavirus Infection",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF99": {
            "ref_id": "b99",
            "title": "Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury",
            "authors": [
                {
                    "first": "L",
                    "middle": [
                        "A"
                    ],
                    "last": "Ortiz",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Dutreil",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Fattman",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Proc Natl Acad Sci U S A",
            "volume": "104",
            "issn": "",
            "pages": "11002--11007",
            "other_ids": {}
        },
        "BIBREF100": {
            "ref_id": "b100",
            "title": "Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice",
            "authors": [
                {
                    "first": "N",
                    "middle": [],
                    "last": "Gupta",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Su",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Popov",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "J Immunol",
            "volume": "179",
            "issn": "",
            "pages": "1855--1863",
            "other_ids": {}
        },
        "BIBREF101": {
            "ref_id": "b101",
            "title": "Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Moodley",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Atienza",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Manuelpillai",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Am J Pathol",
            "volume": "175",
            "issn": "",
            "pages": "303--313",
            "other_ids": {}
        },
        "BIBREF102": {
            "ref_id": "b102",
            "title": "Mesenchymal stem cells for acute lung injury: preclinical evidence",
            "authors": [
                {
                    "first": "M",
                    "middle": [
                        "A"
                    ],
                    "last": "Matthay",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Goolaerts",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [
                        "P"
                    ],
                    "last": "Howard",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Crit Care Med",
            "volume": "38",
            "issn": "",
            "pages": "569--573",
            "other_ids": {}
        },
        "BIBREF103": {
            "ref_id": "b103",
            "title": "Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Kumamoto",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Nishiwaki",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Matsuo",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Eur Respir J",
            "volume": "34",
            "issn": "",
            "pages": "740--748",
            "other_ids": {}
        },
        "BIBREF104": {
            "ref_id": "b104",
            "title": "Mesenchymal Stem Cells in Fibrotic Disease",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "El Agha",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kramann",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [
                        "K"
                    ],
                    "last": "Schneider",
                    "suffix": ""
                }
            ],
            "year": 2017,
            "venue": "Cell Stem Cell",
            "volume": "21",
            "issn": "",
            "pages": "166--177",
            "other_ids": {}
        },
        "BIBREF105": {
            "ref_id": "b105",
            "title": "Treatment with convalescent plasma for influenza A (H5N1) infection",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Zhou",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Zhong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Guan",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "N Engl J Med",
            "volume": "357",
            "issn": "",
            "pages": "1450--1451",
            "other_ids": {}
        },
        "BIBREF106": {
            "ref_id": "b106",
            "title": "Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Van Griensven",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Edwards",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "De Lamballerie",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "N Engl J Med",
            "volume": "374",
            "issn": "",
            "pages": "33--42",
            "other_ids": {}
        },
        "BIBREF107": {
            "ref_id": "b107",
            "title": "Passive immunization against poliomyelitis: the Hammon gamma globulin field trials",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "R"
                    ],
                    "last": "Rinaldo",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Am J Public Health",
            "volume": "95",
            "issn": "",
            "pages": "790--799",
            "other_ids": {}
        },
        "BIBREF108": {
            "ref_id": "b108",
            "title": "Use of convalescent plasma therapy in SARS patients in Hong Kong",
            "authors": [
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Cheng",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [
                        "O"
                    ],
                    "last": "Soo",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Eur J Clin Microbiol Infect Dis",
            "volume": "24",
            "issn": "",
            "pages": "44--46",
            "other_ids": {}
        },
        "BIBREF109": {
            "ref_id": "b109",
            "title": "The management of coronavirus infections with particular reference to SARS",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "S"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "Y"
                    ],
                    "last": "Yuen",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Antimicrob Chemother",
            "volume": "62",
            "issn": "",
            "pages": "437--441",
            "other_ids": {}
        },
        "BIBREF112": {
            "ref_id": "b112",
            "title": "Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ter Meulen",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [
                        "B"
                    ],
                    "last": "Bakker",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "N"
                    ],
                    "last": "Van Den Brink",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Lancet",
            "volume": "363",
            "issn": "",
            "pages": "2139--2141",
            "other_ids": {}
        },
        "BIBREF113": {
            "ref_id": "b113",
            "title": "Human monoclonal antibody combination against SARS coronavirus: synergy and coverage of escape mutants",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Ter Meulen",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [
                        "N"
                    ],
                    "last": "Van Den Brink",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [
                        "L"
                    ],
                    "last": "Poon",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "PLoS Med",
            "volume": "3",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF114": {
            "ref_id": "b114",
            "title": "An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Traggiai",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Becker",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Subbarao",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "Nat Med",
            "volume": "10",
            "issn": "",
            "pages": "871--875",
            "other_ids": {}
        },
        "BIBREF115": {
            "ref_id": "b115",
            "title": "A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2",
            "authors": [
                {
                    "first": "S",
                    "middle": [
                        "K"
                    ],
                    "last": "Wong",
                    "suffix": ""
                },
                {
                    "first": "W",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [
                        "J"
                    ],
                    "last": "Moore",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Biol Chem",
            "volume": "279",
            "issn": "",
            "pages": "3197--3201",
            "other_ids": {}
        },
        "BIBREF116": {
            "ref_id": "b116",
            "title": "Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Tian",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Huang",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "Emerg Microbes Infect",
            "volume": "9",
            "issn": "",
            "pages": "382--385",
            "other_ids": {}
        },
        "BIBREF117": {
            "ref_id": "b117",
            "title": "an active component of liquorice roots, and replication of SARS-associated coronavirus",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Cinatl",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Morgenstern",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Bauer",
                    "suffix": ""
                }
            ],
            "year": 2003,
            "venue": "Lancet",
            "volume": "361",
            "issn": "",
            "pages": "2045--2046",
            "other_ids": {}
        },
        "BIBREF118": {
            "ref_id": "b118",
            "title": "Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus",
            "authors": [
                {
                    "first": "G",
                    "middle": [],
                    "last": "Hoever",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Baltina",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Michaelis",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "J Med Chem",
            "volume": "48",
            "issn": "",
            "pages": "1256--1259",
            "other_ids": {}
        },
        "BIBREF119": {
            "ref_id": "b119",
            "title": "Clinical Observation of Therapeutic Effect of Compound Glycyrrhizin on SARS",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Lu H",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Huo N",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Wang G",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF121": {
            "ref_id": "b121",
            "title": "Analysis of the Chest X-ray Manifestations in SARS Patients Treated with Compound Glycyrrhizin",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Wu C",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Xu X",
                    "suffix": ""
                },
                {
                    "first": "",
                    "middle": [],
                    "last": "Lu H",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF123": {
            "ref_id": "b123",
            "title": "Potential Natural Compounds for Preventing 2019-nCoV Infection",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "Q",
                    "middle": [],
                    "last": "Du",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF124": {
            "ref_id": "b124",
            "title": "Anti-SARS coronavirus 3C-like protease effects of Isatis indigotica root and plant-derived phenolic compounds",
            "authors": [
                {
                    "first": "C",
                    "middle": [
                        "W"
                    ],
                    "last": "Lin",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [
                        "J"
                    ],
                    "last": "Tsai",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [
                        "H"
                    ],
                    "last": "Tsai",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Antiviral Res",
            "volume": "68",
            "issn": "",
            "pages": "36--42",
            "other_ids": {}
        },
        "BIBREF125": {
            "ref_id": "b125",
            "title": "In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [
                        "H"
                    ],
                    "last": "Chan",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Jiang",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Clin Virol",
            "volume": "31",
            "issn": "",
            "pages": "69--75",
            "other_ids": {}
        },
        "BIBREF126": {
            "ref_id": "b126",
            "title": "Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Chen",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Luo",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Bioorg Med Chem",
            "volume": "14",
            "issn": "",
            "pages": "8295--8306",
            "other_ids": {}
        },
        "BIBREF127": {
            "ref_id": "b127",
            "title": "Small molecules blocking the entry of severe acute respiratory syndrome coronavirus into host cells",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Yi",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                }
            ],
            "year": 2004,
            "venue": "J Virol",
            "volume": "78",
            "issn": "",
            "pages": "11334--11339",
            "other_ids": {}
        },
        "BIBREF128": {
            "ref_id": "b128",
            "title": "Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Chai",
                    "suffix": ""
                },
                {
                    "first": "L",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF130": {
            "ref_id": "b130",
            "title": "Caution on Kidney Dysfunctions of 2019-nCoV Patients",
            "authors": [
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Wu",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                }
            ],
            "year": 2020,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {
                "DOI": [
                    "10.1101/2020.02.08"
                ]
            }
        },
        "BIBREF131": {
            "ref_id": "b131",
            "title": "ACE2 Expression in Kidney and Testis May Cause Kidney and Testis Damage After 2019-nCoV Infection",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Fan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Ding",
                    "suffix": ""
                }
            ],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "be a potential intermediate host for SARS-CoV2. However, it needs further confirmation whether COVID-19 is transmitted directly from bats or by an intermediate host. Learning from the roles of camel in MERS-CoV and civet in SARS-CoV, hunting for the source of SARS-CoV2 will help determine zoonotic transmission patterns and stem the ongoing outbreak.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "animal populations and the identification of novel CoVs in reservoir species do not support this view. Therefore, in addition to develop new drugs and clinical trials of old drugs, the design and development of vaccines for SARS-CoV2 are also needed. Lessons from SARS-CoV and MERS-CoV suggest that SARS-CoV2 research should focus on the establishment of animal models that recapitulate the various aspects of human disease and determinants of vaccine safety and efficacy. Declarations Funding: This work was supported by the Natural Science Foundation of China (No.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure legends",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "The structure and genome of SARS-CoV2. A. Four structural proteins are as follows: spike protein (S-purple), membrane protein (M-orange), nucleocapsid protein (N-blue), and envelope protein (E-green). Genome RNA is shown encased in N. B. The SARS-CoV2 genome is arranged in the order of 5\u2032-replicase (ORF1a/b)-structural proteins [Spike (S)-Envelope (E)-Membrane (M)-Nucleocapsid (N)]\u22123\u2032.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "At present, the National Health Commission of the People's Republic of China has recorded a total of 80,304 confirmed cases of pneumonia with SARS-CoV2 infection from 34 provinces (districts and cities). These included 6,806 serious illnesses and 2,946 deaths. By 24:00 on March 3, 2,308 suspected cases were recorded, 664,899 with close contacts to the confirmed patients have been tracked, 7,650 people were released from medical observation that day, and 40,651 people were still undergoing medical observation. A total of confirmed cases were reported from Macao, Hong Kong and Taiwan of China: 10 cases in Macao, 93 cases in Hong Kong, and 34 cases in Taiwan. In addition to China, 46 different countries from Western Pacific Asia, Northern America, Eastern Mediterranean, Southeast Asia, African and Europe have reported the confirmed cases of this disease making the total tally of confirmed cases to 90,870 worldwide.",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "Competing Interests: The authors declare that there is no conflict of interests regarding the publication of this paper.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "annex"
        }
    ]
}